Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.19.3
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Operating expenses:    
Research and development $ 1,887,367 $ 1,421,482
General and administrative 1,820,043 989,748
Total operating expenses 3,707,410 2,411,230
Loss from operations (3,707,410) (2,411,230)
Other income (expenses):    
Change in fair value of derivative liabilities (318,541)
Interest income (expense), net 37,916 (650,322)
Total other income (expenses) 37,916 (968,863)
Net loss $ (3,669,494) $ (3,380,093)
Net loss per common share - basic and diluted $ (0.38) $ (1.08)
Weighted average number of common shares outstanding - basic and diluted 9,761,188 3,137,468